APOE and early-onset autosomal dominant Alzheimer disease: In both analyses, each region has three stages of increasing abnormality relative to a control group that is expected to be at minimal risk of Alzheimer’s disease (in both cases: amyloid-negative, APOE ε4−, cognitively normal participants).